Stay updated on Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Sign up to get notified when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.

Latest updates to the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check45 days agoChange DetectedThe page has been updated to include new collaborators, specifically Merck Sharp & Dohme LLC and the Big Ten Cancer Research Consortium, and the study revision has been updated to v2.15.0. Additionally, the study title has been modified to reflect the focus on Clear Cell Renal Carcinoma.SummaryDifference48%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check60 days agoChange DetectedThe web page has been updated to version 2.14.3, replacing the previous version 2.14.2.SummaryDifference0.0%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
Stay in the know with updates to Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.